Disclaimer: the information presented in the tables below has been provided exclusively by the manufacturers and has been verified with the national drug regulatory authorities only in some cases. When the information obtained only from the manufacturer, the name of the country that granted approval is written in normal font. When the information has been confirmed or has been provided by the national drug regulatory authority, the name of the country in which regulatory approval has been obtained is written in italics. WHO has not verified this information by asking documentary evidence of the market approvals listed. This information will be updated as new data becomes available, including WHO's six-monthly surveys of manufacturers. WHO has made every effort to ensure the accuracy of the regulatory information presented in this report, but the readers should bear in mind that regulatory approvals are a highly dynamic area, and that data can therefore never be complete. The data and information contained herein are being provided as received and WHO makes no representations or warranties, either expressed or implied, as to their accuracy, completeness or fitness for a particular purpose. WHO accepts no responsibility or liability with regard to the reliance on, or use of, such data and information. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by WHO in preference to others of a similar nature that are not specifically mentioned. However, some products on this list have been pre-qualified for procurement by the WHO pre-qualification project, and have been endorsed by the Organization for procurement by the UN. This is the only endorsement WHO gives to pharmaceutical products. The list of WHO pre-qualified products is available at http://mednet3.who.int/prequal/.

Reader’s attention is also drawn to the importance of quality assurance for pharmaceutical products. Licensing authorities in the countries of origin are expected to be responsible for the review and approval of the composition and formulation when authorizing a pharmaceutical product to be marketed, including the specifications of its ingredients, as submitted by the manufacturer of the dosage form, and to oversee compliance with Good Manufacturing Practice requirements as recommended by WHO. Errors or omissions excepted, the names of proprietary products are distinguished by initial capital letters. The designations employed and the presentation of the material in this report, including tables, do not imply the expression of any opinion whatsoever on the part of WHO concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.